<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03441867</url>
  </required_header>
  <id_info>
    <org_study_id>Award Number W81XWH-17-1-0619</org_study_id>
    <nct_id>NCT03441867</nct_id>
  </id_info>
  <brief_title>Neuroimaging Biomarker for Seizures</brief_title>
  <acronym>NIBMSZS</acronym>
  <official_title>Neuroimaging Biomarker for Seizures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Providence VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ocean State Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Providence VA Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-site study will examine patients with epilepsy (ES) following head injury [i.e.,
      posttraumatic epilepsy (PTE)] and posttraumatic psychogenic Non-epileptic seizures (PNES) and
      will compare them to patients with traumatic brain injury (TBI) who do not have seizures
      using functional neuroimaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Numerous Veterans and civilians have seizures, which can be epileptic or nonepileptic in
      nature. Epileptic seizures are caused by abnormal brain cell firing. Nonepileptic seizures
      appear similar to epileptic seizures, but are associated with traumatic experiences and
      underlying psychological stressors. Both types of seizure are common and disabling, and many
      patients with seizures do not have adequate control resulting in loss of quality of life.

      In this proposed 3-site study ( Providence, RI and Birmingham, AL), which are epilepsy
      centers with expertise both in epilepsy and psychogenic nonepileptic seizures (PNES), we will
      enroll 88 patients with video-EEG confirmed PNES and 88 with confirmed post-traumatic
      epilepsy (PTE) and will obtain functional neuroimaging before and after they receive a
      behavioral treatment - Cognitive Behavioral Therapy for Seizures. The functional neuroimaging
      studies in these 176 Veterans will be compared to 88 Veterans with traumatic brain injury
      without seizures to test the hypothesis that the faulty processing of emotions and stress in
      patients with PNES/PTE and abnormal brain connectivity have unique signals in patients with
      seizures compared to Veterans without seizures and that the neuroimaging signatures can be
      modified using behavioral intervention.

      Impact: This grant application for the first study investigating mechanisms of PNES and PTE
      will provide increased understanding of neural circuitry in PTE and PNES, which can inform
      PTE and PNES treatments and could change clinical neurologic and psychiatric practice for PTE
      and PNES.

      Participants will be recruited at the Providence VA Medical Center, Rhode Island Hospital,
      and University of Alabama, Birmingham (UAB).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>The neuroimaging analysis will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Epileptic Seizures</measure>
    <time_frame>Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline</time_frame>
    <description>epileptic seizure frequency (ES), collected prospectively, using a daily seizure calendar</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Nonepileptic Seizures (NES)</measure>
    <time_frame>Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline</time_frame>
    <description>psychogenic nonepileptic seizure (NES) frequency, collected prospectively, using a daily seizure calendar</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Structural and Functional Neuroimaging</measure>
    <time_frame>Baseline and week 13</time_frame>
    <description>Brain MRI scans</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline</time_frame>
    <description>The BDI-II assesses depression severity from &quot;0&quot; (no Depression-related symptom) to &quot;3&quot; (severe) on each question. The highest possible score is &quot;51&quot;, relating to the worst outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory (BAI)</measure>
    <time_frame>Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline</time_frame>
    <description>The BDI-II assesses anxiety severity from &quot;0&quot; (no Anxiety-related symptom) to &quot;3&quot; (severe) on each question.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-31 (QOLIE-31)</measure>
    <time_frame>Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12</time_frame>
    <description>his is a 31-item self-report scale used in the seizure population to evaluate Quality of Life. The lowest possible score is 0 and the highest possible score is 100, reflecting a better quality of life.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">264</enrollment>
  <condition>Seizure Disorder</condition>
  <condition>Seizure Disorder, Post Traumatic</condition>
  <condition>Traumatic Brain Injury</condition>
  <condition>Non-Epileptic Seizure</condition>
  <condition>Conversion Disorder</condition>
  <condition>Magnetic Resonance Imaging</condition>
  <arm_group>
    <arm_group_label>(CBT-Sz) - PNES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants with history of a head injury and confirmed PNES will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(CBT-Sz) - PTE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants with history of a head injury and confirmed post-traumatic epilepsy (PTE) will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TBI Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants with TBI will complete 2 brain fMRI scans.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for Seizures</intervention_name>
    <description>CBT-informed psychotherapy for patients with PNES and PTE</description>
    <arm_group_label>(CBT-Sz) - PNES</arm_group_label>
    <arm_group_label>(CBT-Sz) - PTE</arm_group_label>
    <other_name>Cognitive Behavioral Therapy (CBT-Sz)</other_name>
    <other_name>(CBT-Sz) - PNES</other_name>
    <other_name>(CBT-Sz) - PTE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Medical Care</intervention_name>
    <description>Observational - standard medical care</description>
    <arm_group_label>(CBT-Sz) - PNES</arm_group_label>
    <arm_group_label>(CBT-Sz) - PTE</arm_group_label>
    <arm_group_label>TBI Control</arm_group_label>
    <other_name>Treatment as Usual</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion criteria for PNES, ES and TBI (w/o PNES or ES) participants

               -  Individuals with history of documented TBI (any severity).

               -  Males and Females ages 18-60 years .

               -  Women of child bearing potential, if currently using appropriate contraception.

        Inclusion criteria of PNES and ES participants.

          -  Diagnosed by video/EEG with lone PNES or by EEG with lone ES.

          -  Patients must have at least 1 PNES or 1 ES during the year prior to enrollment.

        Exclusion Criteria:

          -  Exclusion Criteria of PNES, ES and TBI (w/o PNES or ES) participants

               -  Current or past year self-injurious behavior.

               -  Current suicidal intent (BDI suicide question 9 score of &gt;1).

               -  Current or past year psychosis.

               -  Pending litigation or current application for long term disability.

               -  Active substance or alcohol use disorder (dependence), in past 3 months.

               -  Serious illness requiring systemic treatment or hospitalization; the participant
                  either completes therapy or is clinically stable on therapy, for at least 30 days
                  prior to study entry.

               -  Inability to fill out the self-report surveys.

               -  Women who are or/are attempting to become pregnant during the study.

               -  Ineligible or unwilling to complete MRI imaging.

               -  Inability to document TBI.

        Exclusion Criteria for PNES and ES participants

          -  Inability or unwillingness to participate in CBT and assigned homework.

          -  Currently enrolled in cognitive therapy aimed at PNES (Current CBT or other
             psychotherapy may be administered).

          -  Concurrent mixed ES/PNES or equivocal video/EEG findings in discerning between ES and
             PNES will not be enrolled.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>W. Curt LaFrance, Jr., MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence VA Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerzy Szarflarski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>W. Curt LaFrance, Jr., MD, MPH</last_name>
    <phone>401-273-7100</phone>
    <phone_ext>2441</phone_ext>
    <email>william_lafrance_jr@brown.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Krista Tocco, BA</last_name>
    <phone>401-273-7100</phone>
    <phone_ext>6229</phone_ext>
    <email>Krista.Tocco@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama, Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Martin, MPH</last_name>
      <phone>205-975-4219</phone>
      <email>ambermartin@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Jerzy Szaflarski, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jane Allendorfer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Bolding, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lawrence Ver Hoef, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tyler Gaston, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leslie Perry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krista Tocco</last_name>
      <phone>401-273-7100</phone>
      <phone_ext>6229</phone_ext>
      <email>Krista.Tocco@va.gov</email>
    </contact>
    <investigator>
      <last_name>Andrew Blum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Machan, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence VA Medical Center</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krista Tocco</last_name>
      <phone>401-273-7100</phone>
      <phone_ext>6229</phone_ext>
      <email>Krista.Tocco@va.gov</email>
    </contact>
    <investigator>
      <last_name>W. Curt LaFrance, Jr., MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noah Philip, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Correia, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI, Machan JT, Miller I, Szaflarski JP; NES Treatment Trial (NEST-T) Consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014 Sep;71(9):997-1005. doi: 10.1001/jamapsychiatry.2014.817.</citation>
    <PMID>24989152</PMID>
  </reference>
  <reference>
    <citation>Salinsky M, Spencer D, Boudreau E, Ferguson F. Psychogenic nonepileptic seizures in US veterans. Neurology. 2011 Sep 6;77(10):945-50. doi: 10.1212/WNL.0b013e31822cfc46.</citation>
    <PMID>21893668</PMID>
  </reference>
  <reference>
    <citation>LaFrance WC Jr, Friedman JH. Cognitive behavioral therapy for psychogenic movement disorder. Mov Disord. 2009 Sep 15;24(12):1856-7. doi: 10.1002/mds.22683. Erratum in: Mov Disord. 2010 Oct 15;25(13):2268.</citation>
    <PMID>19562779</PMID>
  </reference>
  <reference>
    <citation>LaFrance WC Jr, Keitner GI, Papandonatos GD, Blum AS, Machan JT, Ryan CE, Miller IW. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology. 2010 Sep 28;75(13):1166-73. doi: 10.1212/WNL.0b013e3181f4d5a9. Epub 2010 Aug 25.</citation>
    <PMID>20739647</PMID>
  </reference>
  <reference>
    <citation>Reiter JM, Andrews DJ. A neurobehavioral approach for treatment of complex partial epilepsy: efficacy. Seizure. 2000 Apr;9(3):198-203.</citation>
    <PMID>10775516</PMID>
  </reference>
  <reference>
    <citation>Elsas SM, Gregory WL, White G, Navarro G, Salinsky MC, Andrews DJ. Aura interruption: the Andrews/Reiter behavioral intervention may reduce seizures and improve quality of life - a pilot trial. Epilepsy Behav. 2011 Dec;22(4):765-72. doi: 10.1016/j.yebeh.2011.09.030. Epub 2011 Nov 6.</citation>
    <PMID>22056814</PMID>
  </reference>
  <reference>
    <citation>Michaelis R, Schonfeld W, Elsas SM. Trigger self-control and seizure arrest in the Andrews/Reiter behavioral approach to epilepsy: a retrospective analysis of seizure frequency. Epilepsy Behav. 2012 Mar;23(3):266-71. doi: 10.1016/j.yebeh.2011.11.023. Epub 2012 Feb 15.</citation>
    <PMID>22341960</PMID>
  </reference>
  <reference>
    <citation>Allendorfer JB, Szaflarski JP. Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy: response to a biochemical evaluation. Epilepsy Behav. 2014 Dec;41:312-3. doi: 10.1016/j.yebeh.2014.08.018. Epub 2014 Oct 11.</citation>
    <PMID>25306199</PMID>
  </reference>
  <reference>
    <citation>Szaflarski JP, Ficker DM, Cahill WT, Privitera MD. Four-year incidence of psychogenic nonepileptic seizures in adults in hamilton county, OH. Neurology. 2000 Nov 28;55(10):1561-3.</citation>
    <PMID>11094115</PMID>
  </reference>
  <reference>
    <citation>LaFrance WC Jr, Syc S. Depression and symptoms affect quality of life in psychogenic nonepileptic seizures. Neurology. 2009 Aug 4;73(5):366-71. doi: 10.1212/WNL.0b013e3181b04c83.</citation>
    <PMID>19652140</PMID>
  </reference>
  <reference>
    <citation>Szaflarski JP, Hughes C, Szaflarski M, Ficker DM, Cahill WT, Li M, Privitera MD. Quality of life in psychogenic nonepileptic seizures. Epilepsia. 2003 Feb;44(2):236-42.</citation>
    <PMID>12558580</PMID>
  </reference>
  <reference>
    <citation>Voon V, Brezing C, Gallea C, Ameli R, Roelofs K, LaFrance WC Jr, Hallett M. Emotional stimuli and motor conversion disorder. Brain. 2010 May;133(Pt 5):1526-36. doi: 10.1093/brain/awq054. Epub 2010 Apr 5.</citation>
    <PMID>20371508</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2017</study_first_submitted>
  <study_first_submitted_qc>February 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Veterans</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Stress Disorders, Post-Traumatic</keyword>
  <keyword>Convulsion, Non-Epileptic</keyword>
  <keyword>civilians</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Conversion Disorder</mesh_term>
    <mesh_term>Hysteria</mesh_term>
    <mesh_term>Dissociative Disorders</mesh_term>
    <mesh_term>Epilepsy, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

